As of Oct 26, 2026: Praxis Precision Medicines (PRAX) has a PDUFA date for relutrigine on Dec 27, 2026, in 62 days. Its Quality Score is -4. Scores as of 9:21 PM ET, 15 minutes behind.

PRAX FDA decision on Relutrigine

Praxis Precision Medicines · PDUFA date

PDUFA dateDec 27in 62 days Quality Score-4Poor

Cash runway–into 2028

What the company said

“PDUFA date of December 27, 2026”

PDUFA date, Dec 27, 2026. As Praxis Precision Medicines stated in its 8-K of Aug 6, 2026 (the filing).

A PDUFA date is the day the FDA has said it aims to decide on a drug. The FDA can decide earlier, or extend its review, often by three months.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Get an alert before PRAX's FDA date

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

How PRAX's stock moved on its past FDA days, for Pro members. Pro members also see whether its cash lasts past Dec 27, and the members' FDA calendar with filters and optional alerts.

More on PRAX and the FDA calendar

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

The FDA calendar.